← Browse by Condition
Medical Condition

relapsed and or refractory multiple myeloma

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1, Phase 2
NCT05719701 Phase 1, Phase 2
Recruiting

Evaluate the Safety, Tolerability, and Efficacy of ICP-490 in Patients With Relapsed and/or Refractory Multiple Myeloma

Enrollment
80 pts
Location
China
Sponsor
Beijing InnoCare Pharma Tech C...
View Trial →